Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Number of Campylobacter jejuni isolates tested for resistance to erythromycin
The primary objectives of NARMS are to:
In 1997, surveillance for Campylobacter in NARMS began in sites participating in the Foodborne Disease Active Surveillance Network (FoodNet). There were 5 participating sites in 1997. Since 2003 10 FoodNet sites have been participating: California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New York, New Mexico, Oregon, and Tennessee. The 10 FoodNet sites represent about 98 million or 32% of the US population (US Census, 2010) Participating sites forward Participating sites forward a representative sample of Campylobacter isolates received at their public health laboratories to NARMS at CDC for susceptibility testing. Susceptibility testing involves determination of minimum inhibitory for 9 antimicrobial agents: azithromycin, ciprofloxacin, clindamycin, erythromycin, florfenicol, gentamicin, nalidixic acid, telithromycin, and tetracycline.
Additional resources about the objective.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link